N/A
Completed N=21
Radiofrequency of Breast Cancers in Non Surgical Patients
Source: ClinicalTrials.gov NCT00210223 ↗Enrolled (actual)
21
Serious AEs
—
Results posted
Oct 2025
Primary outcomePrimary: Number of Participants With Disease Recurrence One Year After the Intervention. — 1 Participants
Summary
To determine the efficacy and tolerance of ultrasonography (US)-guided percutaneous radiofrequency (RF) ablation with endocrine therapy in elderly patients with breast cancer who decline or are not candidates for surgery.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Participants With Disease Recurrence One Year After the Intervention. |
1 | — |
| SECONDARY Number of Participants With Disease Recurrence at 5 Years |
4 | — |
Eligibility Criteria
Inclusion criteria
- Patients more than 70 years old
- Breast tumors with estrogen receptors
- Non surgical patients
- Life expectancy more than 6 months
Exclusion criteria
- Presence of a pace maker
- Tumors measuring more than 30 mm on ultrasound evaluation, located less than 10 mm from skin, nipple, or pectoral muscle
- Coagulation disorders
- Contra indications to magnetic resonance imaging or computed tomography with contrast medium injection
- Non visible lesions on magnetic resonance imaging or computed tomography with contrast medium injection
Data sourced from ClinicalTrials.gov (NCT00210223). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.